Hold Rating on Merit Medical Systems Amid Modest Growth Projections and Market Caution
Merit Medical Systems Analyst Ratings
Oppenheimer Raises Merit Medical Systems Price Target to $87 From $82, Maintains Outperform Rating
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Jazz Pharmaceuticals (JAZZ) and Natera (NTRA)
Merit Medical Systems Earns 'Buy' Rating on Strong Q4 Performance and Promising Growth Outlook
Merit Medical Systems Analyst Ratings
Merit Medical Systems Analyst Ratings
Buy Rating on Merit Medical Systems Backed by Strong Growth and Positive Q4 Outlook
Piper Sandler Maintains Overweight on Merit Medical Systems, Raises Price Target to $95
Merit Medical Systems Analyst Ratings
Merit Medical Systems (MMSI) Gets a Buy From Piper Sandler
Hold Rating on Merit Medical Systems Amid Mixed Growth Signals and Pending Wrapsody Impact
Hold Rating on Merit Medical Systems Amid Growth and Awaited Financial Details
Merit Medical Systems Surpasses Q4 Revenue Expectations, Secures Buy Rating
Canaccord Genuity Upgrades Merit Medical Systems to Buy From Hold, Adjusts Price Target to $100 From $76
Piper Sandler Sticks to Their Buy Rating for Merit Medical Systems (MMSI)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Merit Medical Systems (MMSI) and Masimo (MASI)
Merit Medical Systems Had A Solid Q3, But This Analyst Has Lowered The Price Target On The Stock
Analysts Offer Insights on Healthcare Companies: CVRx (CVRX) and Merit Medical Systems (MMSI)
Needham Maintains Buy on Merit Medical Systems, Lowers Price Target to $81
No Data